Muckle-Wells Syndrome

8 clinical trials · Condition

Record	Firm	Date
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease (NCT01576367)	Novartis Pharmaceuticals	2012-01-16
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease (NCT01302860)	Novartis Pharmaceuticals	2010-11-01
A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease (NCT01211977)	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	2010-08-27
Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase (NCT00991146)	Novartis Pharmaceuticals	2009-10-01
Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS) (NCT01045772)	Charite University, Berlin, Germany	2009-01-01
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease (NCT00685373)	Novartis	2008-05-01
Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome (NCT00465985)	Novartis	2007-04-01

Track Muckle-Wells Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.